These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 32181480

  • 1. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X, Huang Q, Wang S, Huang Z, Yu F, Lin J.
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr 20; 52(4):345-362. PubMed ID: 32181480
    [Abstract] [Full Text] [Related]

  • 2. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ, Dong BK, Fan M, Jiang WX.
    Int J Clin Exp Pathol; 2015 Apr 20; 8(10):12410-8. PubMed ID: 26722427
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F, Zhou P, Wang Z, Zhang XL, Liao FX, Hu Y, Chang J.
    Arch Biochem Biophys; 2020 Jun 15; 686():108351. PubMed ID: 32240636
    [Abstract] [Full Text] [Related]

  • 4. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
    Chen Y, Huang W, Sun W, Zheng B, Wang C, Luo Z, Wang J, Yan W.
    Cell Physiol Biochem; 2018 Jun 15; 51(3):1313-1326. PubMed ID: 30481748
    [Abstract] [Full Text] [Related]

  • 5. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y, Cheng H, Li W, Wu H, Yang Y.
    Int J Cancer; 2019 Aug 15; 145(4):1068-1082. PubMed ID: 30761524
    [Abstract] [Full Text] [Related]

  • 6. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
    Zhang X, Qu P, Zhao H, Zhao T, Cao N.
    Mol Med Rep; 2019 Oct 15; 20(4):3811-3819. PubMed ID: 31485669
    [Abstract] [Full Text] [Related]

  • 7. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C, Zhang B, Li YL, Yu XR.
    Biomed Pharmacother; 2018 Sep 15; 105():10-17. PubMed ID: 29807230
    [Abstract] [Full Text] [Related]

  • 8. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X.
    Tumour Biol; 2015 Mar 15; 36(3):1477-86. PubMed ID: 25431257
    [Abstract] [Full Text] [Related]

  • 9. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J, Liu C, Shi J, Wen K, Wang X.
    Mol Med Rep; 2022 Feb 15; 25(2):. PubMed ID: 34913077
    [Abstract] [Full Text] [Related]

  • 10. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R, Wu JX, Zhang Y, Che H, Yang L.
    Eur Rev Med Pharmacol Sci; 2018 Sep 15; 22(18):5857-5866. PubMed ID: 30280767
    [Abstract] [Full Text] [Related]

  • 11. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H, Yin M, Qian W, Yin H.
    Med Sci Monit; 2018 Sep 05; 24():6178-6186. PubMed ID: 30182951
    [Abstract] [Full Text] [Related]

  • 12. CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP-9/PI3K/AKT pathway.
    Chen H, Pan R, Li H, Zhang W, Ren C, Lu Q, Chen H, Zhang X, Nie Y.
    Cell Biol Int; 2021 Mar 05; 45(3):623-632. PubMed ID: 33245175
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F, Tian L, Zhou Q, Feng D.
    Gene; 2019 Dec 30; 721():144093. PubMed ID: 31473323
    [Abstract] [Full Text] [Related]

  • 16. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
    Huang S, Jin A.
    J Cell Biochem; 2018 Feb 30; 119(2):2248-2257. PubMed ID: 28857346
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX, Xue HQ, Sun L, Sun C, Feng W, Guo SB.
    Oncol Rep; 2020 Apr 30; 43(4):1169-1186. PubMed ID: 32323781
    [Abstract] [Full Text] [Related]

  • 18. TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis.
    Zhao GS, Gao ZR, Zhang Q, Tang XF, Lv YF, Zhang ZS, Zhang Y, Tan QL, Peng DB, Jiang DM, Guo QN.
    J Exp Clin Cancer Res; 2018 Aug 09; 37(1):188. PubMed ID: 30092789
    [Abstract] [Full Text] [Related]

  • 19. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
    Qu Q, He Z, Jiang Y, Lu D, Long X, Ding Y, Xu B, He X.
    Med Sci Monit; 2019 Oct 07; 25():7527-7537. PubMed ID: 31589596
    [Abstract] [Full Text] [Related]

  • 20. Effect of CXCR4 on Apoptosis in Osteosarcoma Cells via the PI3K/Akt/NF-κβ Signaling Pathway.
    Jiang C, Ma S, Hu R, Wang X, Li M, Tian F, Jiang W, Zhu L, Bian Z.
    Cell Physiol Biochem; 2018 Oct 07; 46(6):2250-2260. PubMed ID: 29734183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.